VetClick logo News
Thursday, 24th May 2012 | 3517 veterinary jobs online | 269 people actively seeking work | 3432 practices registered
Veterinary News /

Introducing Onsior – Effective Pain Relief For Cats And Dogs

Author: Novartis
Posted: Wednesday 16th September, 2009. 00:00:00

First and only coxib class NSAID for both cats and dogs

A new fast-acting pain reliever which concentrates at the site of inflammation

Available as both an injectable solution and flavoured tablets

Onsior logoOnsior®, the first and only coxib NSAID (non-steroidal anti-inflammatory drug) for the relief of pain and inflammation in both cats and dogs, will be launched by Novartis Animal Health on September 15th 2009.

Traditionally, NSAIDs inhibit both COX-2 and COX-1 enzymes which can result in common side effects involving the gastrointestinal tract and the kidneys. Onsior, however, targets the pain-causing COX-2 enzymes while sparing the protective actions of COX-1 and is the only coxib licensed for cats as well as dogs.

Tissue selectivity is a further benefit of Onsior. The drug travels rapidly through the bloodstream to the site of injury or irritation. It then concentrates at the point of inflammation, while exiting the bloodstream very quickly.

Dosed once daily, Onsior has an excellent safety profile and fits different administration routes with pain and inflammatory indications, which are:
  • An injectable solution for surgery (soft tissue in cats and soft tissue or orthopaedic surgery in dogs)


  • Flavoured tablets, for pain and inflammation related to chronic osteoarthritis in dogs or acute pain and inflammation associated with musculoskeletal disorders in cats
Kelly Doucette, DVM, Global Technical Services Manager with Novartis Animal Health says: “With the benefits of being tissue selective, sparing COX-1, and having a short blood half-life – as well as being approved for both cats and dogs – Onsior will stand out as the new pain reliever of choice for vets.”

Folkert Kamphuis, COO Novartis Animal Health adds: “Onsior covers multiple indications, works for cats and dogs, comes in two formulations – oral and injectable – and is very simple to dose, which allows veterinarians to use it as the cornerstone of pain management in their clinics. With this complete range, Onsior will offer to veterinarians a convenient solution addressing all their different needs.”

This article has been viewed 5767 times.

 

Comments about this article

Most recent from this author

Novartis Animal Health Adds Adequan® Equine To Its Veterinary Line In The UK

Novartis Novartis Animal Health, Inc. announced that it will market and distribute Adequan® Equine in the UK beginning in early January 2011. Thi...
Posted: Friday 10th December, 2010. 13:05:44

Novartis Animal Health UK Announce Commitment To Provide A Reliable Supply Of BVD Vaccine

Novartis Novartis Animal Health UK announce commitment to provide a reliable supply of BVD vaccineNovartis Animal Health UK Ltd today announce a comm...
Posted: Monday 20th September, 2010. 14:48:34

Scottish Expert Fears For Future Of Worm Control

Novartis A senior lecturer at the University of Edinburgh’s Royal (Dick) School of Veterinary Studies has warned that the national problem of anthelm...
Posted: Tuesday 10th November, 2009. 00:00:00

More Novartis news items...


Related



VetClick™ provides internet services for busy veterinary professionals. Jobs, staff, news, forum, referral practices, practice websites and veterinary consumables

All material on this website © Copyright VetClick (UK) Ltd 2000 - 2012 All rights reserved

Web design, web development and maintenance by Symbiotic

Monitored by Pingdom